Blog Details

F33.2 Diagnosis Code Explained: Symptoms, Billing, and ICD-10 Guidelines

In the landscape of mental health diagnosis and medical billing, few codes carry as much clinical and administrative significance as F33.2. It represents Major Depressive Disorder (MDD), recurrent, severe, without psychotic features a condition that affects tens of millions of people worldwide and demands precise documentation, careful coding, and evidence-based treatment. Whether you are a psychiatrist, a licensed clinical social worker, a medical coder, or a billing specialist, understanding F33.2 in its entirety from its diagnostic criteria to its reimbursement implications is not optional. It is foundational.

What Is the F33.2 ICD-10 Code?

The ICD-10-CM code F33.2 falls under the broader category of F33 Major Depressive Disorder, recurrent. The ICD-10-CM (International Classification of Diseases, Tenth Revision, Clinical Modification) is the standardized coding system used across the United States for diagnosis documentation, insurance billing, and epidemiological tracking.

Breaking down the code hierarchy helps clarify its precise meaning:

• F Mental, behavioral, and neurodevelopmental disorders
• F33 Major depressive disorder, recurrent
• F33.2 Major depressive disorder, recurrent, severe, without psychotic features

The distinction between “severe” and other specifiers is not trivial. It directly affects treatment decisions, the level of care recommended, the medications considered, and the reimbursement tier assigned by insurance payers.

Related Codes in the F33 Family

To appreciate F33.2 fully, it helps to understand the broader code family:

ICD-10 Code	Description
F33.0	MDD, recurrent, mild
F33.1	MDD, recurrent, moderate
F33.2	MDD, recurrent, severe, without psychotic features
F33.3	MDD, recurrent, severe, with psychotic features
F33.40	MDD, recurrent, in remission, unspecified
F33.41	MDD, recurrent, in partial remission
F33.42	MDD, recurrent, in full remission

The “without psychotic features” qualifier in F33.2 is particularly important it distinguishes this form of severe depression from F33.3, which involves hallucinations, delusions, or other psychotic elements that require an entirely different treatment protocol and often a higher level of psychiatric care.

Clinical Symptoms That Justify F33.2

For a clinician to assign F33.2 with accuracy and defensibility, the patient must meet specific diagnostic criteria. These are primarily drawn from the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition), which the ICD-10-CM system aligns with for clinical practice in the United States.

Core DSM-5 Criteria for Major Depressive Disorder

The patient must exhibit five or more of the following symptoms during the same two-week period, with at least one being either depressed mood or loss of interest/pleasure:

• Depressed mood most of the day, nearly every day
• Markedly diminished interest or pleasure in almost all activities (anhedonia)
• Significant weight change gain or loss of more than 5% body weight in a month, or changes in appetite
• Insomnia or hypersomnia nearly every day
• Psychomotor agitation or retardation observable by others
• Fatigue or loss of energy nearly every day
• Feelings of worthlessness or excessive guilt
• Difficulty concentrating, thinking, or making decisions
• Recurrent thoughts of death, suicidal ideation, or a suicide attempt

What Makes the Episode “Severe”?

The severity specifier what makes this F33.2 rather than F33.0 or F33.1 — requires that the number of symptoms significantly exceeds the minimum five required, AND that those symptoms cause marked functional impairment. Specifically, the patient’s ability to work, maintain relationships, and perform basic self-care is substantially compromised.

Clinicians typically use validated severity scales to document this:

• PHQ-9 (Patient Health Questionnaire-9): A score of 20–27 indicates severe depression
• HAM-D (Hamilton Depression Rating Scale): A score above 23 indicates very severe depression
• MADRS (Montgomery-Åsberg Depression Rating Scale): Scores above 34 indicate severe depression

Documenting these scores in the clinical record strengthens the medical necessity argument for F33.2 and protects against payer audits.

The “Recurrent” Qualifier Explained

For F33.2 as opposed to F32.2 (single episode, severe) the patient must have had at least two separate depressive episodes with a period of remission of at least two consecutive months in between. This history of recurrence is clinically significant: it increases the likelihood of future episodes, informs long-term medication strategy, and affects prognosis discussions with the patient.

Clinical Symptoms That Justify F33.2

For a clinician to assign F33.2 with accuracy and defensibility, the patient must meet specific diagnostic criteria. These are primarily drawn from the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition), which the ICD-10-CM system aligns with for clinical practice in the United States.

Core DSM-5 Criteria for Major Depressive Disorder

The patient must exhibit five or more of the following symptoms during the same two-week period, with at least one being either depressed mood or loss of interest/pleasure:

• Depressed mood most of the day, nearly every day
• Markedly diminished interest or pleasure in almost all activities (anhedonia)
• Significant weight change gain or loss of more than 5% body weight in a month, or changes in appetite
• Insomnia or hypersomnia nearly every day
• Psychomotor agitation or retardation observable by others
• Fatigue or loss of energy nearly every day
• Feelings of worthlessness or excessive guilt
• Difficulty concentrating, thinking, or making decisions
• Recurrent thoughts of death, suicidal ideation, or a suicide attempt

What Makes the Episode “Severe”?

The severity specifier what makes this F33.2 rather than F33.0 or F33.1 — requires that the number of symptoms significantly exceeds the minimum five required, AND that those symptoms cause marked functional impairment. Specifically, the patient’s ability to work, maintain relationships, and perform basic self-care is substantially compromised.

Clinicians typically use validated severity scales to document this:

• PHQ-9 (Patient Health Questionnaire-9): A score of 20–27 indicates severe depression
• HAM-D (Hamilton Depression Rating Scale): A score above 23 indicates very severe depression
• MADRS (Montgomery-Åsberg Depression Rating Scale): Scores above 34 indicate severe depression

Documenting these scores in the clinical record strengthens the medical necessity argument for F33.2 and protects against payer audits.

The “Recurrent” Qualifier Explained

For F33.2 as opposed to F32.2 (single episode, severe) the patient must have had at least two separate depressive episodes with a period of remission of at least two consecutive months in between. This history of recurrence is clinically significant: it increases the likelihood of future episodes, informs long-term medication strategy, and affects prognosis discussions with the patient.

F33.2 and Comorbid Conditions

Severe recurrent depression rarely exists in isolation. Clinicians and coders must be aware of the common comorbidities that frequently accompany an F33.2 diagnosis, as these often require additional codes and influence treatment planning.

Frequently co-occurring diagnoses include:

• F41.1 – Generalized Anxiety Disorder (GAD): Depression and anxiety frequently co-occur, with estimates suggesting more than 50% of patients with MDD also meet criteria for an anxiety disorder
• F10.20 – Alcohol use disorder: Substance use disorders are common in patients with severe depression, often complicating treatment
• F50.2 or F50.00 – Eating disorders: Particularly relevant given appetite changes as a core symptom of MDD
• G47.00 – Insomnia: Frequently documented separately when it requires its own treatment intervention
• E11.9 – Type 2 diabetes and other chronic medical conditions: The bidirectional relationship between depression and metabolic disorders is well-established

When billing, the principal diagnosis should reflect the condition chiefly responsible for the patient visit. In most outpatient mental health visits where the primary concern is depression, F33.2 will be the principal diagnosis, with comorbidities listed as secondary codes.

ICD-10 Documentation Guidelines for F33.2

Accurate coding starts with accurate, thorough documentation. Insurance payers increasingly use AI-driven audit tools that cross-reference diagnosis codes against the documented clinical record. If your notes do not support F33.2, the claim is vulnerable regardless of how clinically appropriate the code may be.

What the Clinical Note Must Include

1. Evidence of Severity the note must demonstrate that symptoms are severe not just present. Phrases like “patient reports significant impairment in occupational and social functioning” or documented PHQ-9 scores in the severe range provide this evidence.

2. Recurrence Documentation reference prior depressive episodes explicitly. “This represents the patient’s third major depressive episode; previous episodes occurred in 2019 and 2022” is the kind of language that supports the recurrent specifier.

3. Absence of Psychotic Features since F33.2 explicitly excludes psychosis, the note should confirm that the patient denies and the clinician did not observe delusions, hallucinations, or formal thought disorder.

4. Functional Impairment document how the disorder affects daily life. Inability to maintain employment, disrupted interpersonal relationships, compromised self-care, and withdrawal from previously enjoyed activities are all relevant.

5. Medical Necessity for Intervention the note should support whatever treatment is being rendered whether psychotherapy, pharmacotherapy, or a higher level of care such as intensive outpatient programming (IOP) or inpatient admission.

Billing Considerations for F33.2

CPT Codes Commonly Paired with F33.2

When submitting claims for services related to F33.2, the appropriate CPT (Current Procedural Terminology) codes depend on the service rendered:

CPT Code	Service
90791	Psychiatric diagnostic evaluation
90832	Psychotherapy, 30 minutes
90834	Psychotherapy, 45 minutes
90837	Psychotherapy, 60 minutes
90847	Family psychotherapy with patient present
99213/99214	Evaluation and management (E&M) medication management
99213 + 90833	E&M with add-on psychotherapy
90853	Group psychotherapy

Insurance Payer Considerations

Most major commercial payers including UnitedHealthcare, Aetna, Cigna, and BlueCross BlueShield recognize F33.2 as a covered diagnosis under mental health parity laws. However, payers may require:

• Prior authorization for higher levels of care (IOP, residential, inpatient)
• Medical necessity documentation beyond a simple code assignment
• Treatment plan updates at regular intervals to justify continued care
• Progress notes that reflect measurable clinical improvement or ongoing medical necessity for treatment

Under the Mental Health Parity and Addiction Equity Act (MHPAEA), insurers must cover mental health conditions at levels comparable to medical/surgical benefits. F33.2, as a severe mental health diagnosis, should trigger parity protections but coders and providers must document carefully to take full advantage of these protections.

Telehealth and F33.2

The expansion of telehealth reimbursement following the COVID-19 pandemic has made it easier to deliver mental health services to patients with severe depression, many of whom struggle to leave home. When billing F33.2 via telehealth, append the appropriate place-of-service code:

• POS 02 Telehealth provided other than in the patient’s home
• POS 10 Telehealth provided in the patient’s home

Some payers also require a GT modifier or 95 modifier on the CPT code. Always verify payer-specific telehealth requirements before submission.

Treatment Standards Associated with F33.2

While this article is not a clinical treatment guide, it is worth noting what evidence-based care looks like for a patient with a severe, recurrent MDD diagnosis both because it influences billing and because it reflects the standard of care that documentation should support.

Pharmacotherapy

For severe MDD without psychotic features, antidepressant medication is generally indicated. First-line options include SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). When patients fail to respond to multiple medication trials, augmentation strategies including atypical antipsychotics, lithium, or thyroid hormone may be employed.

Psychotherapy

Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT) have the strongest evidence base for recurrent MDD. For severe presentations, a combination of medication and therapy tends to produce better outcomes than either alone.

Higher Levels of Care

A patient meeting F33.2 criteria who is experiencing suicidal ideation, significant self-neglect, or functional collapse may warrant referral to:

• Partial Hospitalization Programs (PHP)
• Intensive Outpatient Programs (IOP)
• Inpatient psychiatric hospitalization

These levels of care have their own billing codes and authorization requirements, but they all begin with the same foundational diagnosis: F33.2.

Common Coding Errors to Avoid

Even experienced coders make mistakes with F33.2. Here are the most frequent errors:

1. Confusing F33.2 with F32.2 is a single episode of severe MDD. F33.2 requires documented recurrence. Assigning the wrong code is a compliance risk.

2. Upgrading from Moderate Without Documentation moving from F33.1 (moderate) to F33.2 (severe) must be supported by clinical notes. The severity cannot simply be inferred.

3. Using F33.2 When Psychotic Features Are Present if the patient is experiencing hallucinations or delusions, the correct code is F33.3 not F33.2.

4. Failing to Update the Diagnosis if a patient achieves remission, continuing to bill F33.2 is inaccurate. Transition to F33.41 or F33.42 as appropriate.

5. Missing Secondary Diagnosis Codes leaving comorbidities uncoded results in an incomplete clinical picture and may limit reimbursement for services addressing those conditions.